Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C. Diff Colitis”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Early research (Phase 1)Study completedNCT01551004
What this trial is testing

Phase I Trial of a Single Dose of CRS3123

Who this might be right for
Clostridium Difficile Colitis
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT01232595
What this trial is testing

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Who this might be right for
Moderate Clostridium Difficile Infection
Novartis Pharmaceuticals 109
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT04305769
What this trial is testing

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Who this might be right for
Clostridioides Difficile InfectionClostridium Difficile InfectionClostridium Difficile Diarrhea+1 more
University of Virginia 260
Not applicableStudy completedNCT01930032
What this trial is testing

Pathogenic Mechanisms in C Diff Infection and Colitis

Who this might be right for
Clostridium Difficile Infection
Beth Israel Deaconess Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00417872
What this trial is testing

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

Who this might be right for
Clostridium Difficile
Romark Laboratories L.C. 114
Not applicableWithdrawnNCT02968511
What this trial is testing

EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant

Who this might be right for
C.Difficile Colitis
Milton S. Hershey Medical Center
Not applicableUnknownNCT01942447
What this trial is testing

Fecal Microbiota Transplantation in Recurrent or Refractory Clostridium Difficile Colitis

Who this might be right for
Clostridium DifficileClostridium Difficile Infection
University Hospital Tuebingen 30
Post-approval studies (Phase 4)UnknownNCT01630096
What this trial is testing

Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe

Who this might be right for
Clostridium Difficile Colitis
Ascension Health 200
Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Testing effectiveness (Phase 2)Study completedNCT01230957
What this trial is testing

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Sanofi Pasteur, a Sanofi Company 650
Not applicableEnded earlyNCT01346059
What this trial is testing

Intracolonic Vancomycin Therapy in Severe C. Diff Colitis

Who this might be right for
Colitis
Corewell Health East 2
Testing effectiveness (Phase 2)Study completedNCT00034294
What this trial is testing

GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Clostridium Difficile-Associated DiarrheaClostridium EnterocolitisClostridium Difficile Diarrhea+2 more
Genzyme, a Sanofi Company 300
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Not applicableUnknownNCT01973465
What this trial is testing

Fecal Microbiota Therapy for Recurrent Clostridium Difficile Colitis

Who this might be right for
Clostridium Difficile
OSF Healthcare System 10
Early research (Phase 1)Enrolling By InvitationNCT01868373
What this trial is testing

Defined Fecal Microbiota Transplantation for Clostridium Difficile Diarrhea

Who this might be right for
Active C. Difficile Colitis
Baylor College of Medicine 12
Post-approval studies (Phase 4)Study completedNCT02748616
What this trial is testing

C. Difficile and Ursodiol

Who this might be right for
Diarrhea
NYU Langone Health 9
Not applicableEnded earlyNCT01441271
What this trial is testing

Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis

Who this might be right for
Clostridium Difficile Colitis
Massachusetts General Hospital 1
Large-scale testing (Phase 3)Study completedNCT00196794
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisDiarrhea
Genzyme, a Sanofi Company 520
Not applicableStudy completedNCT00304889
What this trial is testing

Vancomycin vs. Nitazoxanide to Treat Recurrent C. Difficile Colitis

Who this might be right for
Clostridium EnterocolitisPseudomembranous ColitisAntibiotic-Associated Colitis
Michael E. DeBakey VA Medical Center 52
Load More Results